Dupont Capital Management Corp boosted its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 85.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 3,308 shares of the medical instruments supplier’s stock after purchasing an additional 1,520 shares during the quarter. Dupont Capital Management Corp’s holdings in DENTSPLY SIRONA were worth $218,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Janney Montgomery Scott LLC boosted its stake in DENTSPLY SIRONA by 2.0% in the 3rd quarter. Janney Montgomery Scott LLC now owns 41,335 shares of the medical instruments supplier’s stock worth $2,472,000 after purchasing an additional 830 shares during the period. BB&T Corp boosted its stake in DENTSPLY SIRONA by 5.9% in the 4th quarter. BB&T Corp now owns 15,528 shares of the medical instruments supplier’s stock worth $1,022,000 after purchasing an additional 866 shares during the period. Harvey Investment Co. LLC boosted its stake in DENTSPLY SIRONA by 0.4% in the 3rd quarter. Harvey Investment Co. LLC now owns 210,927 shares of the medical instruments supplier’s stock worth $12,616,000 after purchasing an additional 900 shares during the period. Security National Bank of Sioux City Iowa IA boosted its stake in DENTSPLY SIRONA by 3.9% in the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 23,990 shares of the medical instruments supplier’s stock worth $1,435,000 after purchasing an additional 909 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec boosted its stake in DENTSPLY SIRONA by 4.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 23,608 shares of the medical instruments supplier’s stock worth $1,418,000 after purchasing an additional 1,000 shares during the period. Institutional investors and hedge funds own 96.56% of the company’s stock.

DENTSPLY SIRONA Inc (XRAY) opened at $57.18 on Friday. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $13,057.47, a P/E ratio of -16.48, a PEG ratio of 2.10 and a beta of 1.18. DENTSPLY SIRONA Inc has a 52-week low of $52.53 and a 52-week high of $68.98.

The company also recently announced a quarterly dividend, which was paid on Friday, January 12th. Stockholders of record on Friday, December 29th were given a dividend of $0.0875 per share. The ex-dividend date was Thursday, December 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.

XRAY has been the subject of several recent analyst reports. Credit Suisse Group downgraded DENTSPLY SIRONA to a “hold” rating and set a $73.00 price target for the company. in a research note on Friday, January 5th. HC Wainwright downgraded DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target for the company. in a research note on Thursday, November 30th. Zacks Investment Research downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. JPMorgan Chase & Co. upgraded DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price target for the company in a research note on Wednesday, December 13th. Finally, Deutsche Bank initiated coverage on DENTSPLY SIRONA in a research note on Friday, December 8th. They issued a “buy” rating and a $81.00 price target for the company. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $69.15.

In other news, Director Eric Brandt sold 6,409 shares of the stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the transaction, the director now directly owns 12,073 shares in the company, valued at approximately $821,446.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Francis J. Lunger sold 8,900 shares of the stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $65.90, for a total value of $586,510.00. The disclosure for this sale can be found here. 1.99% of the stock is currently owned by corporate insiders.

WARNING: “DENTSPLY SIRONA Inc (XRAY) Holdings Lifted by Dupont Capital Management Corp” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://theolympiareport.com/2018/02/11/dentsply-sirona-inc-xray-holdings-lifted-by-dupont-capital-management-corp.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.